Screening of bioactive peptides using an embryonic stem cell-based neurodifferentiation assay

Area of Science:

• Stem cell biology
• Neuroscience
• Biotechnology

Background:

• Pluripotent stem cells (PSCs) differentiation into neural lineages is crucial for regenerative medicine and in vitro studies.
• Identifying specific bioactive molecules that direct this differentiation is a key research objective.

Purpose of the Study:

• To identify novel bioactive peptides that can effectively direct pluripotent stem cell differentiation towards neural lineages.
• To explore the potential of these peptides as tools for neuroscience research and regenerative medicine.

Main Methods:

• Designed fifteen peptides based on Neural Cell Adhesion Molecule (NCAM), Fibroblast Growth Factor Receptor (FGFR), and growth factor sequences.
• Screened peptide efficacy using a mouse embryonic stem cell line with a dual luciferase reporter system.
• Quantified cell number via total cellular DNA measurement to assess differentiation without significant proliferation.

Main Results:

• Identified five peptides that enhanced neural promoter activities without altering cell numbers.
• Selected two potent peptides, FGLL (NCAM mimetic) and Plannexin (synthetic NCAM ligand), for further investigation.
• Confirmed that both FGLL and Plannexin induced phenotypic neuronal differentiation, characterized by increased neurite outgrowth.

Conclusions:

• Developed a sensitive screening method to identify neurogenic peptides.
• The identified peptides provide insights into neurogenesis pathways.
• These peptides represent promising biotechnology tools for the in vitro generation of neurons.